Submitted by Anonymous (not verified) on 10 October 2023 - 8:53
Human medicines European public assessment report (EPAR): Zubsolv, buprenorphine,naloxone, Opioid-Related Disorders, Date of authorisation: 10/11/2017, Revision: 10, Status: Authorised
Source: